April 2020 HSC Section 4 - Plastic and Reconstructive Problems

Management of Lymphatic Malformations

6. Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 2011;57(6):1018–24 . 7. Mulliken J, Burrows PE, Fishman SJ, et al. Mulliken and Young’s vascular anom- alies: hemangiomas and malformations. New York: Oxford University Press; 2013 . 8. Fonkalsrud EW. Lymphatic disorders. In: Grosfeld JL, O’Neil JA Jr, editors. Pedi- atric Surgery. 6th edition. Philadelpia: Elsevier; 2006. p. 2137–46 . 9. Wiggs WJ Jr, Sismanis A. Cystic hygroma in the adult: two case reports. Otolar- yngol Head Neck Surg 1994;110(2):239–41 . 10. Surico D, Amadori R, D’Ajello P, et al. Antenatal diagnosis of fetal lymphangioma by ultrasonography. Eur J Obstet Gynecol Reprod Biol 2013;168(2):236 . 11. Aslan A, Buyukkaya R, Tan S, et al. Efficacy of ultrasonography in lymphatic mal- formations: diagnosis, treatment and follow-up: a case report. Med Ultrason 2013;15(3):244–6 . 12. Longstreet B, Balakrishnan K, Saltzman B, et al. Prognostic value of a simplified anatomically based nomenclature for fetal nuchal lymphatic anomalies. Otolar- yngol Head Neck Surg 2015;152(2):342–7 . 13. Smith MC, Zimmerman MB, Burke DK, et al. Efficacy and safety of OK-432 immu- notherapy of lymphatic malformations. Laryngoscope 2009;119(1):107–15 . 14. Eliasson JJ, Weiss I, Hogevold HE, et al. An 8-year population description from a national treatment centre on lymphatic malformations. J Plast Surg Hand Surg 2017;51(4):280–5 . 15. O TM, Kwak R, Portnof JE, et al. Analysis of skeletal mandibular abnormalities associated with cervicofacial lymphatic malformations. Laryngoscope 2011; 121(1):91–101 . 16. O TM, Rickert SM, Diallo AM, et al. Lymphatic malformations of the airway. Oto- laryngol Head Neck Surg 2013;149(1):156–60 . 17. Greene AK, Burrows PE, Smith L, et al. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg 2005;115(1):22–30 . 18. Burrows PE, Laor T, Paltiel H, et al. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998;16(3):455–88 . 19. Hassanein AH, Mulliken JB, Fishman SJ, et al. Lymphatic malformation: risk of progression during childhood and adolescence. J Craniofac Surg 2012;23(1): 149–52 . 20. Morgan P, Keller R, Patel K. Evidence-based management of vascular malforma- tions. Facial Plast Surg 2016;32(2):162–76 . 21. Balakrishnan K, Bauman N, Chun RH, et al. Standardized outcome and reporting measures in pediatric head and neck lymphatic malformations. Otolaryngol Head Neck Surg 2015;152(5):948–53 . 22. Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 2008;138(4):418–24 . 23. Giguere CM, Bauman NM, Sato Y, et al. Treatment of lymphangiomas with OK- 432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolar- yngol Head Neck Surg 2002;128(10):1137–44 . 24. Mathur NN, Rana I, Bothra R, et al. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhino- laryngol 2005;69(1):75–80 . 25. Raveh E, de Jong AL, Taylor GP, et al. Prognostic factors in the treatment of lymphatic malformations. Arch Otolaryngol Head Neck Surg 1997;123(10): 1061–5 .

234